Investor teach-in

RNS Number : 3346J

Venn Life Sciences Holdings PLC

02 April 2015

 

Venn Life Sciences Holdings Plc

("Venn" or the "Company" or the "Group")

Investor teach-in

Venn Life Sciences (AIM: VENN), a growing Clinical Research Organisation (CRO) providing clinical trial management and resourcing solutions to pharmaceutical, biotechnology and medical device clients, will be hosting a teach-in where Tony Richardson, CEO will provide an overview and strategy of the Company on Tuesday 21 April 2015. No new material trading or financial information will be disclosed.

The event is open to all investors and analysts and will be held from 16:30 until 19:30 in the Black Bar at Rocket Bar, 6 Adams Court, Old Broad Street, London, EC2N 1DX and will be followed by drinks and canapés.

To register for the event, please email [e-mail] or call the Walbrook PR team below.

Enquiries:

Venn Life Sciences Holdings Plc	www.vennlifesciences.com
Tony Richardson, Chief Executive Officer	Tel: [phone]
Orla Mc Guinness, Marketing Manager	Tel: [phone]
Zeus Capital (Nominated Adviser and Broker)
Ross Andrews/Andrew Jones	Tel: [phone]
Alex Davies	Tel: [phone]
Walbrook PR Ltd	Tel: [phone] or [e-mail]
Paul McManus	Mob: [phone]
Lianne Cawthorne	Mob: [phone]

About Venn Life Sciences Limited:

Venn Life Sciences is a Clinical Research Organisation providing clinical trial management and resourcing solutions to pharmaceutical, biotechnology and medical device organisations. With dedicated operations in France, Germany, the Netherlands, the UK, Ireland and Europe wide representation - Venn specialises in rapid deployment and management of multisite projects. Venn recently established an innovation division - Innovenn - focused primarily on breakthrough development opportunities in Skin Science.

 

END

 

 

NRAFLLFBEZFEBBX